Cited by 634Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 139 of the 142 references it cites were found in a registry or an index.

Improving cancer immunotherapy through nanotechnology

Goldberg, Michael S.·2019·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

The 2018 Nobel Prize in Physiology or Medicine was awarded to pioneers in the field of cancer immunotherapy, as the utility of leveraging a patient's coordinated and adaptive immune system to fight the patient's unique tumour has now been validated robustly in the clinic. Still, the proportion of patients who respond to immunotherapy remains modest (~15% objective response rate across indications), as tumours have multiple means of immune evasion. The immune system is spatiotemporally controlled, so therapies that influence the immune system should be spatiotemporally controlled as well, in order to maximize the therapeutic index. Nanoparticles and biomaterials enable one to program the location, pharmacokinetics and co-delivery of immunomodulatory compounds, eliciting responses that cannot be achieved upon administration of such compounds in solution. The convergence of cancer immunotherapy, nanotechnology, bioengineering and drug delivery is opportune, as each of these fields has matured independently to the point that it can now be used to complement the others substantively and rationally, rather than modestly and empirically. As a result, unmet needs increasingly can be addressed with deductive intention. This Review explores how nanotechnology and related approaches are being applied to augmenting both endogenous leukocytes and adoptively transferred ones by informing specificity, influencing localization and improving function.

Integrity signals

Registry

Crossref · 10.1038/s41568-019-0186-9

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Hugo, W., Zaretsky, J. M., Sun, L., Song, C., Moreno, B. H., Hu-Lieskovan, S., Berent-Maoz, B., Pang, J., Chmielowski, B., Cherry, G., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.065 · Cited by 3,448

Show all 142 references

Research works printed but not linked: 2

Luteijn, R. et al. SLC19A1 is a cyclic dinucleotide transporter. Preprint at bioRxiv https://www.biorxiv.org/content/10.1101/539767v1 (2019). · DOI
Nature Collection: Nobel Prize in Physiology or Medicine 2018, https://www.nature.com/collections/gqznlfngkz (2018).

Sorted by citations

Items 401–500 of 634

Nanomaterials in gene therapy and genome editing: challenges and emerging directions
Jiang, M., Zhang, K., Wang, Z., Gao, M., Su, S., He, J., Xu, H., Bo, Z., Jiang, Z., Zhang, C., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03895-w · Cited by 14
Harnessing cGAS‐STING Pathway for Cancer Immunotherapy: From Bench to Clinic
Lee, D., Huntoon, K. M., Kang, M., Lü, Y., Gallup, T. D., Jiang, W., & Kim, B. Y. S. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200040 · Cited by 10
Pseudopyrolysis of Metal–Organic Frameworks: A Synchronous Nucleation Mechanism to Synthesize Ultrafine Metal Compound Nanoparticles
Cui, Z., Liu, Q., Zhu, J., Wang, H., Gao, M., Wang, W., Yuen, M., Hu, J., Chen, H., & Zou, R. (2023) · Nano Letters · doi:10.1021/acs.nanolett.2c04244 · Cited by 11
Immortalized nanodendritic cells decorated with immune-checkpoint inhibitors for personalized cancer immunotherapy
Choi, D., Kang, T. G., Kim, T., Moon, C.-W., Choi, M., Kim, D., Kim, T., Oh, Y., Sung-Won, J., Lee, Y., et al. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102237 · Cited by 11
Antibody‐Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
Chae, Y. J., Lee, K.-G., Oh, D., Lee, S., Park, Y., & Kim, J. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400235 · Cited by 11
Nanotechnology‐Assisted CAR ‐T‐Cell Therapy for Tumor Treatment
Wang, Y., Barrett, A., & Hu, Q. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.2005 · Cited by 11
Controllable synthesis and biomedical applications of bismuth-based nanospheres: enhanced photothermal therapy and CT imaging efficiency
Chen, D., Miao, B., Zhu, G., Liang, Y., & Wang, C. (2024) · Nanoscale · doi:10.1039/d4nr04024d · Cited by 11
Ultrasound-activated nanovesicles for adenosine exhaustion and immune checkpoint blockade in cancer immunotherapy
Li, Z., Zhang, B., Duan, S., Liu, R., Wang, Y., Wang, Y., Zhang, J., Huang, R. Y., Jiang, R., Zhang, R., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113988 · Cited by 11
Nanotherapies from an oncologist doctor's view
Liu, S., Li, L., Zhang, X., & Meng, Q. (2022) · Smart Materials in Medicine · doi:10.1016/j.smaim.2022.07.005 · Cited by 11
Cell membrane-camouflaged liposomes and neopeptide-loaded liposomes with TLR agonist R848 provides a prime and boost strategy for efficient personalized cancer vaccine therapy
Shi, L. D., & Gu, H. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102648 · Cited by 11
Hyperbranched Polymer‐Based Vaccines for Cancer Immunotherapy
Wang, Z., Guo, Y., Shen, M., Wang, Y., & Shi, X. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300188 · Cited by 11
The role of ion channels in the relationship between the immune system and cancer
Erdoğan, M. A., Ugo, D., & Fasolino, I. (2023) · Current topics in membranes · doi:10.1016/bs.ctm.2023.09.001 · Cited by 12
Carrier-Free Small-Molecule Drug Nanoassembly Elicits Chemoimmunotherapy via Co-inhibition of PD-L1/mTOR
Yang, Q., Xiao, Y., Liu, Q., Xu, X., & Peng, J. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00470 · Cited by 11
Immune evasion by designer microrobots
Sakar, M. S. (2020) · Science Robotics · doi:10.1126/scirobotics.abc7620 · Cited by 11
Systemically administered silica nanoparticles result in diminished T cell response in lung
Dai, H., Fan, Q., Fei, Z., Ma, Q., Yang, Q., Chu, J., Zhou, X., Zhang, Y., Dong, Z., Xu, F., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101332 · Cited by 11
Strategies of Perturbing Ion Homeostasis for Cancer Therapy
Lee, D., Ha, J., Kang, M., Yang, Z., Jiang, W., & Kim, B. Y. S. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202100189 · Cited by 11
Cancer Nanotechnology
Jiang, X., Liu, Y., Liu, D. X., Shi, J., & Langer, R. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm070.pub2 · Cited by 11
Beta-Adrenergic Blockade in Advanced Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Multicentric Study
Mendes, A. D., Freitas, A. R., Vicente, R. S., Ferreira, R., Martins, T., Ramos, M. J., Baptista, C., Silva, B. M., Margarido, I., Vitorino, M. M., et al. (2024) · Cureus · doi:10.7759/cureus.52194 · Cited by 10
A multi-adjuvant nanovaccine platform based on targeted delivery of specific antigens for cancer immunotherapy
Li, W., Zhang, Q., Ma, X., Zeng, X., & Zhang, X. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102481 · Cited by 10
Production, Characterization, and Application of Hydrophobin‐Based IR780 Nanoparticles for Targeted Photothermal Cancer Therapy and Advanced Near‐Infrared Imaging
Yang, J., Wang, W., Huang, S., Guo, D., Long, Y., Qiao, W., Zhang, X., Han, Z., Song, B., Xu, X., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402311 · Cited by 10
The Role of ERO1? in Modulati ng Cancer Progression and Immune Escape
Johnson, B. D., Geldenhuys, W. J., & Hazlehurst, L. (2020) · Journal of Cancer Immunology · doi:10.33696/cancerimmunol.2.023 · Cited by 10
Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Silveira, M. J., Castro, F., Oliveira, M. J., & Sarmento, B. F. C. C. (2021) · Biomaterials Science · doi:10.1039/d1bm00137j · Cited by 10
Targeting Indoleamine 2,3-Dioxygenase 1: Fighting Cancers via Dormancy Regulation
Yang, C., Ng, C. E., Li, D., & Zhang, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.725204 · Cited by 10
Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review
Huang, T. L., Liu, L., Lv, Z., Zhao, K., Yi, Q., & Zhang, J. (2022) · Vaccines · doi:10.3390/vaccines10101586 · Cited by 11
Antibody and Cellular-Based Therapies for Pediatric Acute Lymphoblastic Leukemia: Mechanisms and Prospects
Li, W., Zhang, Y., Kankala, R. K., Zou, L., & Chen, Z. (2022) · Pharmacology · doi:10.1159/000524040 · Cited by 9
Nanomedicine-mediated immunogenic cell death and its combination with immune checkpoint blockade therapy
Chen, J., Zhang, Y., Su, M., Zhu, Y., & Yang, X. (2024) · Science China Technological Sciences · doi:10.1007/s11431-023-2574-0 · Cited by 9
Deciphering the tumor immune microenvironment: Microscale measurements for precision detection and multidimensional analysis
Wang, L., Yin, F., Luo, R., Dong, F., Lyu, J., Wang, Z., & Zhang, Y. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20240126 · Cited by 9
Emerging Strategies of Cell and Gene Therapy Targeting Tumor Immune Microenvironment
Wang, R., Duan, X., Li, J., Zhang, C., & Shen, L. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-4308 · Cited by 10
Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding
Shi, Y., Pan, C., Wang, K., Liu, Y., Sun, Y., Guo, Y., Sun, P., Wu, J., Lu, Y., Zhu, L., et al. (2022) · Nanomaterials · doi:10.3390/nano12050734 · Cited by 9
A holistic review of recent advances in nano-based drug delivery systems for the treatment of triple-negative breast cancer (TNBC)
Mehta, S., Shah, V., Patel, G. M., Conte‐Júnior, C. A., & Joshi, N. (2024) · Journal of Nanoparticle Research · doi:10.1007/s11051-024-06000-8 · Cited by 10
Excessive autophagy-inducing and highly penetrable biomineralized bacteria for multimodal imaging-guided and mild hyperthermia-enhanced immunogenic cell death
Wu, Y., Qu, H., Liu, X., Liu, X., Wang, L., Xia, X., & Wu, X. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.09.246 · Cited by 9
Simultaneous co-delivery of Ginsenoside Rg3 and imiquimod from PLGA nanoparticles for effective breast cancer immunotherapy
Hu, C., Nong, S., Ke, Q., Wu, Z., Jiang, Y., Wang, Y., Chen, Y., Wu, Z., Zhang, Q., Liao, C., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112274 · Cited by 9
Advanced materials for management of immune-related adverse events induced by immune checkpoint inhibitors
Zheng, L., Yang, X., Wei, Y., You, J., Li, H., Liao, J., & Cheng, Y. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.110738 · Cited by 9
Spatial delivery of immune cues to lymph nodes to define therapeutic outcomes in cancer vaccination
Andorko, J. I., Tsai, S. J., Gammon, J. M., Carey, S. T., Zeng, X., Gosselin, E. A., Edwards, C., Shah, S., Hess, K. L., & Jewell, C. M. (2022) · Biomaterials Science · doi:10.1039/d2bm00403h · Cited by 9
Emerging Advances in Nanomedicine for Breast Cancer Immunotherapy: Opportunities and Challenges
Ahmad, M. Z., Alasiri, A., Alasmary, M. Y., Abdullah, M. M., Ahmad, J., Abdel‐Wahab, B. A., Alqahtani, S. A. M., Pathak, K., Mustafa, G., Khan, M. A., et al. (2022) · Immunotherapy · doi:10.2217/imt-2021-0348 · Cited by 9
Reprogramming tumor-immune cell communication with a radiosensitive nanoregulator for immunotherapy
Chen, Y., Liu, S., Gao, P., Pan, W., Shi, M., Wang, J., Li, N., & Tang, B. (2022) · Science China Materials · doi:10.1007/s40843-022-2140-7 · Cited by 9
DGKα, Bridging Membrane Shape Changes with Specific Molecular Species of DAG/PA: Implications in Cancer and Immunosurveillance
Bozelli, J. C., & Epand, R. M. (2022) · Cancers · doi:10.3390/cancers14215259 · Cited by 9
A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma
Fan, Z., Pei, Q., Sun, H., Zhang, H., Xie, Z., Zhang, T., & Ma, C. (2025) · Advanced Science · doi:10.1002/advs.202414592 · Cited by 8
αPD-1-conjugated acid-cleavable nanodrugs overcomes cellular immunotherapy barriers in pancreatic tumors
Gan, Z., Huang, J., Duan, S., Lin, M., Deng, S., Huang, S., Wang, J., Shuai, X., & Xiao, Z. (2025) · Nature Communications · doi:10.1038/s41467-025-67254-x · Cited by 8
Nano-/nanobio-technology-enhanced CAR-T cell therapy: engineering the next generation of immunotherapies
Zuo, M., Wang, J., Zhang, W., Xiao, L., Qiao, Z., Li, W., Zhao, J., Xiong, K., Yan, X., & Zhang, K. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217388 · Cited by 8
Long‐Term Storage Stable Vesicle‐Like Nanoparticles of Lipid and Polymer for siRNA and mRNA‐Mediated Cancer Immunotherapy
Chen, C., Zhang, Y., Cao, Z., Li, D., Zhu, Y., Jing, H., Li, Y., Li, F., Xu, C., Yang, X., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202406101 · Cited by 8
Two‐Step Targeting‐Tunable Semiconducting Nanoswitches Amplify Mitochondrion Damage and PD‐L1 Blockade for Orthotopic Pancreatic Cancer Therapy
Li, Z., Zhang, Y., Li, M., & Li, J. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202413233 · Cited by 8
Hybrid amorphous TiO2/polymer nanomaterials trigger apoptosis of pediatric cancer cells upon ultrasound irradiation
Pariente, A., Peled, E., Zlotver, I., & Sosnik, A. (2021) · Materials Today Chemistry · doi:10.1016/j.mtchem.2021.100613 · Cited by 8
Challenges and opportunities of nanotechnology in cancer immunotherapy
Lee, D., Huntoon, K. M., Jiang, W., & Kim, B. Y. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90949-5.00024-3 · Cited by 8
Immunotherapeutics for head and neck squamous cell carcinoma stem cells
Qian, X., Leonard, F., Wenhao, Y., Sudhoff, H. H., Hoffmann, T. K., Ferrone, S., Kaufmann, A. M., & Albers, A. E. (2020) · HNO · doi:10.1007/s00106-020-00819-y · Cited by 8
Emerging strategies in lymph node-targeted nano-delivery systems for tumor immunotherapy
Zhao, Y., Tian, M., Tong, X., Yang, X., Gan, L., & Yong, T. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253008 · Cited by 7
Prostate cancer immunotherapy-based strategies: an updated review emphasizing immune checkpoint inhibitors
Lu, H., Teng, Z., Wang, J., & Zhang, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1583363 · Cited by 7
Sono-Destructive Polymeric Nanocapsules Enable Spatiotemporal Orchestration of DC-T Cell Crosstalk in Combined In Situ Vaccination and Cytokine Therapy
Jia, W., Yang, W., Wu, Y., Ren, H., Jia, Y., Ye, W., Xie, Y., Chen, Y., & Yu, M. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c06120 · Cited by 7
Potentiation of the therapeutic effect of intravesical BCG through synthetic and biogenic selenium nanoparticles in a nitrosamine-induced bladder cancer mouse model
Ajideh, R., Pourmand, M. R., Faramarzi, M. A., Sepehrizadeh, Z., Pourmand, G., Hassanzadeh, S. M., Mahdavi, M., Shahverdi, A. R., & Yazdi, M. H. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100061 · Cited by 7
A cleavable self-delivery nanoparticle for tumor photo-immunotherapy
Hu, C., & Gao, H. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.01.001 · Cited by 7
Toward Personalized Immunotherapeutic Drug Monitoring with Multiplexed Extended‐Gate Field‐Effect‐Transistor Biosensors
Nguyen‐Le, T., Neuber, C., Çela, I., Janićijević, Ž., Loureiro, L. R., Hoffmann, L., Feldmann, A., Bachmann, M. P., & Baraban, L. (2025) · Small Science · doi:10.1002/smsc.202400515 · Cited by 6
Maximizing Efficacy of Cancer Nanovaccines and Immune Cells Landscape in Responders and Non‐Responders to Immunotherapy
Xu, X., Diao, L., Wang, J., Zhu, A., Chen, X., Zheng, Y., Liu, Y., Hu, K., Zhu, J., Ding, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202416756 · Cited by 6
Nanodelivery strategies modulating tumor stromal cells for reverting the immunosuppressive tumor microenvironment
Sun, J., Huang, L., Jia, W., Liu, Y., Li, X., Yang, X. H., Tong, F., Wang, X., Gao, H., & Zhang, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.112036 · Cited by 6
Bimetallic Peroxide Nanocomposites‐Driven Redox Dyshomeostasis to Activate Sequential Cuproptosis and Pyroptosis for Amplified Tumor Immunotherapy
He, G., Zhu, H., Kang, P., Feng, L., Yu, C., Zhu, Y., Liu, B., Guo, Z., & Yang, P. (2025) · Advanced Science · doi:10.1002/advs.202512470 · Cited by 6
Peptide-Based Cancer Vaccines: Engineering Immune Precision Against Tumor Evolution
Mehnath, S. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10796-x · Cited by 6
Harnessing targeted protein degradation to potentiate cancer immunotherapy: from molecular mechanisms to delivery strategies
Liu, Y., Ullah, I., Yuan, Y., & Wang, J. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115776 · Cited by 6
Nanomaterials for cancer immunotherapy, what is the next?
Luo, Z., & Liu, X. (2023) · Next Nanotechnology · doi:10.1016/j.nxnano.2023.100006 · Cited by 6
Leveraging Immunotherapy with Nanomedicine
Mittelheisser, V., Banerjee, M., Pivot, X. B., Charbonnière, L. J., Goetz, J. G., & Detappe, A. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000134 · Cited by 6
Nano-oncology: Clinical Application for Cancer Therapy and Future Perspectives
Singh, P., & Sahoo, S. K. (2021) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-76263-6_3 · Cited by 7
A comprehensive review of using nanomaterials in cancer immunotherapy: Pros and Cons of clinical usage
Rashid, H., Acharya, S., Muhammad, H., & Aziz, M. A. (2025) · 3 Biotech · doi:10.1007/s13205-025-04362-x · Cited by 6
Bi‐Functional Topospecific Nanoparticles to Promote Immune‐Tumor Cell Engagement as A New Immunotherapeutic Strategy
Ortuño‐Bernal, A., Trujillo, S. C., Lucena‐Sánchez, E., Hicke, F. J., Escudero, A. C., Pradana‐López, S., Jiménez‐Alduán, N., Díez, P., García‐Fernández, A., & Martínez‐Máñez, R. (2025) · Advanced Materials · doi:10.1002/adma.202418838 · Cited by 5
Polymersome-based nanomedicine for combined cancer therapy
Zonouz, A. M., Ebrahimpour, M., Zibaei, K., Ramezani, M., Taghavi, S., Abnous, K., Taghdisi, S. M., & Alibolandi, M. (2025) · Drug Delivery · doi:10.1080/10717544.2025.2577137 · Cited by 5
The interplay between autophagy and immunogenic cell death: nanomaterial-based strategies for cancer immunotherapy
Khorrami, M., Fadaie, M., Dizaji, S. R., Davoodi, A., Asghari, R., Shen, J., Rahimmanesh, I., Sethi, G., & Makvandi, P. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04286-5 · Cited by 5
Microvascular and stromal normalization combined with nano-immunotherapy: A synergistic strategy to overcome drug delivery barriers in solid tumors
Mirala, F., Kashkooli, F. M., & Soltani, M. (2026) · Microvascular Research · doi:10.1016/j.mvr.2026.104955 · Cited by 6
Photo‐responsive carbon dots for pyroptosis‐mediated anti‐tumor application
Li, L., Wu, X., Yan, Z., Wu, J., Huang, C., & Qu, S. (2026) · Responsive materials · doi:10.1002/rpm2.70067 · Cited by 5
Amplifying cancer chemoimmunotherapy through F4/80+CD11c+ DC-like macrophages induced by micellar docetaxel together with a TLR7/8 nanoagonist
Peng, J., Yang, Q., Jiang, H., Wang, Y., Liu, Q., Xiao, Y., & Qian, Z. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102087 · Cited by 5
Integrating Nanotechnology and Artificial Intelligence for Early Detection and Prognostication of Glioblastoma: A Translational Perspective
Suryawanshi, M. V., Bagban, I., & Patne, A. Y. (2025) · Targets · doi:10.3390/targets3040031 · Cited by 5
Methodological Considerations in Development of UV Imaging for Characterization of Intra-Tumoral Injectables Using cAMP as a Model Substance
Bock, F., Boetker, J. P., Larsen, S. W., Lu, X., & Østergaard, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073599 · Cited by 5
Impact of Macrophages on the Interaction of Cetuximab-Functionalized Polyelectrolyte Capsules with EGFR-Expressing Cancer Cells
Nifontova, G., Kalenichenko, D., Kriukova, I. S., Terryn, C., Audonnet, S., Karaulov, A. V., Nabiev, I. R., & Sukhanova, A. V. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c10864 · Cited by 5
Multiplexable and Scalable Aqueous Synthesis Platform for Oleate‐Based, Bilayer‐Coated Gold Nanoparticles
Backhaus, A., Albrecht, J., Alzhanova, G., Long, A., Arnold, W., Lee, J., Ho-Yin, T. S. E., Su, T. T., Cruz, S. R., Lee, S. S., et al. (2024) · Small · doi:10.1002/smll.202309919 · Cited by 5
Bioactive-material-programmed CAR-T cell living drug for augmented immunotherapy against tumors
Huang, G., Tang, Z., Yin, T., Ma, A.-Q., Gong, H., Zhang, Y., Pan, H., & Cai, L. (2024) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2024.102022 · Cited by 5
RNA technology and nanocarriers empowering in vivo chimeric antigen receptor therapy
Cai, J., Chen, S., Liu, Z., Li, H., Wang, P., Yang, F., Li, Y., Chen, K., Sun, M., & Qiu, M. (2024) · Immunology · doi:10.1111/imm.13861 · Cited by 5
Therapeutic Immunomodulation of Tumor-Lymphatic Crosstalk via Intratumoral Immunotherapy
Lucas, S. N., & Thomas, S. N. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00692 · Cited by 5
Investigating the delivery of PD-L1-targeted immunoliposomes in a dynamic cervical cancer-on-a-chip model
Fobian, S., Amin, M., Sacchetti, A., Oei, A. L., & ten Hagen, T. L. M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.014 · Cited by 5
Biomaterial nanocarrier-driven mechanisms to modulate anti-tumor immunity
Liu, L., Wannemuehler, M. J., & Narasimhan, B. (2021) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2021.100322 · Cited by 5
Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells
Safina, I., Nima, Z. A., Hashoosh, A., Darrigues, E., Watanabe, F., Biris, A. S., Dings, R. P. M., & Vang, K. B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0241882 · Cited by 5
Regulation of cell signaling pathways by Schisandrin in different cancers: Opting for "Swiss Army Knife" instead of "Blunderbuss"
Lin, X., Attar, R., Mobeen, I., Yulaevna, I. M., Aras, A., Butt, G. Y., & Farooqı, A. A. (2021) · Cellular and Molecular Biology · doi:10.14715/cmb/2021.67.2.5 · Cited by 5
CPP Applications in Immune Modulation and Disease Therapy
Koo, J., Kim, W., & Choi, J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1752-6_23 · Cited by 5
Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy
Arroyo-Nogales, A., Plaza-Palomo, G., Gónzalez‐Larre, J., Jiménez‐Falcao, S., & Baeza, A. (2025) · Molecules · doi:10.3390/molecules30061257 · Cited by 5
Tumor cell‐derived vaccines: Advances, challenges, and future prospects
Lu, J., Yu, M., Shi, X., Zhao, Y., Irwin, D. M., Zhang, X., Zhang, Y., Zhu, Q., Tai, Z., & Chen, Z. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.70056 · Cited by 4
Cleavable Hydrophobic Anchors Optimize Immunomodulatory Effects of Oligonucleotides
Luo, T., Kim, Y. J., Cushing, A., Ma, Y., Han, Z., Johnson, R. E., Pascall, M. J. P., & Mirkin, C. A. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c15110 · Cited by 4
Stimuli-responsive STING nanovaccine for systemic therapy of HPV-induced cancers
Chen, S., Ye, S., Huang, G., Sun, Z., Feng, Q., Wang, M., Pantoja, R., Sumer, B. D., & Gao, J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409570122 · Cited by 4
Cascade-amplified iron-doped bismuth sulfide biomimetic nanoplatform for synergistic therapy and multimodal imaging of triple-negative breast cancer
Xie, D., Wu, M., Wang, L., Luo, P., Wei, X., Ye, T., Liu, Y., Chen, T., Wu, A., & Li, Q. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.12.021 · Cited by 4
From innate immunity to precision cancer therapy: the clinical advancement of NK cell therapy
Wang, Y., Yu, Y., Wang, S., Qu, J., & Song, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116373 · Cited by 4
Nanomedicine-based cancer immunotherapy: translational barriers, mechanistic strategies, and future perspectives
Suo, X., Liu, Y., Zhang, G., & Li, Y. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2679846 · Cited by 5
Drug Integrating Amphiphilic Nano-Assemblies: 2. Spatiotemporal Distribution within Inflammation Sites
Toni, T. D., Buono, T. D., Li, C. M., Gonzalez, G. C., Chuang, S.-T., Buchwald, P., Tomei, A. A., & Velluto, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050652 · Cited by 4
Amplifying antitumor T cell immunity with versatile drug delivery systems for personalized cancer immunotherapy
Xiao, P., Li, Y., & Wang, D. (2021) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2021.100116 · Cited by 4
Self-assembled d -arginine derivatives based on click chemical reactions for intracellular codelivery of antigens and adjuvants for potential immunotherapy
He, X., Qu, Y., Lin, X., Sun, J., Jiang, Z., Wang, C., Deng, Y., Yan, F., & Sun, Y. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00346e · Cited by 4
Advancement and Applications of Nanotherapy for Cancer Immune Microenvironment
He, J., Li, Q., Zhao, C., Zhou, J., Wu, J., Zhang, H., Zhao, Y., Zhang, H., Lei, T., Zhao, X., et al. (2023) · Current Medical Science · doi:10.1007/s11596-023-2763-0 · Cited by 4
Cell-derived vesicles for delivery of cancer immunotherapy
Xu, J., & Wang, C. (2021) · Exploration of Medicine · doi:10.37349/emed.2021.00031 · Cited by 4
Engineered DBCO+PD-1 Nanovesicles Carrying 1-MT for Cancer-Targeted Immunotherapy
Xu, X., Liu, L., Wang, H., Li, W., Zou, Y., Zeng, Y., Yang, Q., Bai, D., & Dai, D. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00639 · Cited by 4
Novel insights into immunology-driven nanomaterials for immunomodulatory bone regeneration: from basics to biological functions
Grolle, C., Misra, R. D. K., & Rautray, T. R. (2026) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2026.2676367 · Cited by 3
Biomimetic delivery of a STING agonist via tumor antigen-primed dendritic cell membrane nanovesicles for bladder cancer immunotherapy
Zhang, X., Xin, P., Du, Y., Wang, R., Wang, Y., Bi, J., & (4829), Y. L. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103333 · Cited by 3
Fundamental concepts of injectable hydrogel based on natural polymer for malignant solid tumor: Types and characterization – Review
Córdoba, E. A., Agudelo, N. A., & Echeverri-Cuartas, C. E. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106587 · Cited by 4
Copper Oxide Nanorods: Potential Agents against Breast Cancer
Lôbo, G. C. N. B., Silva, A. L. G., Barros‐Cordeiro, K. B., Almeida, R. D. N., da Silva, I. G. M., Sales, M. P., Paterno, L. G., & Báo, S. N. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01700 · Cited by 3
Activatable Semiconducting Polymer Pro‐nanomodulators for Deep‐Tissue Sono‐immunotherapy of Orthotopic Pancreatic Cancer
Li, J., Yu, N., Cui, D. M., Huang, J., Luo, Y., & Pu, K. (2023) · Angewandte Chemie · doi:10.1002/ange.202305200 · Cited by 3
Simple preparation and high activity for cancer therapy via Zr(IO3)4 nanozyme
Li, J., Liu, R., Liu, P., & Zhou, H. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136948 · Cited by 3
The modulation of tumor-associated macrophages via natural nanomodulators by neutralizing the acidic tumor microenvironment for tumor treatment
Peng, L., Zhang, C., Zhou, G., Yu, A., & Wang, Y. (2023) · Materials Advances · doi:10.1039/d3ma00243h · Cited by 3
NIR-II responsive Janus nanoparticles amplify immunogenic cell death for enhanced cancer immunotherapy
Chen, B., Guo, K., Wang, H., Xu, F., Wang, J.-L., & Zhao, N. (2023) · Science China Technological Sciences · doi:10.1007/s11431-023-2477-9 · Cited by 3
An optically responsive cancer vaccine for inducing robust anti-tumor immunity by apoptotic body carrying nanoadjuvants
Jin, L., Sheng, S., Zhang, Y., Sun, W., Mei, L., Zhu, D., Dong, X., & Lv, F. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.153721 · Cited by 3

Authors: Goldberg, M. S.
Affiliations: Massachusetts Institute of Technology (US)
Corresponding author: Goldberg, Michael S.
ORCID: Goldberg, Michael S.
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2019-09-06
Volume: 19
Issue: 10
Pages: 587-602
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/s41568-019-0186-9
OpenAlex: W2972159813
Cited by: 628
References: 142
Citations by year: 2026: 44 · 2025: 67 · 2024: 81 · 2023: 98 · 2022: 114 · 2021: 122 · 2020: 92 · 2019: 10
FWCI: 8.06
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords: cancer immunotherapy, nanotechnology, nanoparticles, biomaterials, drug delivery, immune evasion, spatiotemporal control, pharmacokinetics, co-delivery, adoptive immunotherapy, tumor targeting, nanomedicine
MeSH terms: Animals, Biocompatible Materials, Humans, Immune System, Immunologic Factors, Immunotherapy, Leukocytes, Neoplasms, Nucleic Acids, T-Lymphocytes, Drug Delivery Systems, Adoptive Transfer, Nanomedicine, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Improving cancer immunotherapy through nanotechnology

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks